Overview

Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma

Status:
Not yet recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
The study was a single-arm study designed to evaluate the efficacy and safety of Chidamide combined with Toripalimab.
Phase:
N/A
Details
Lead Sponsor:
Beijing Cancer Hospital